In a historic move, the U.S. National Institutes of Health (NIH) announced today that it will no longer seek research ...

The White House’s plans to make significant cuts to funding from NIH is expected to have significant impact on the pharma industry for years to come. Justin Kozak, an executive VP at Founder Shield, ...

Cuts to the National Institutes of Health would devastate the system responsible for nearly all our modern medical advances ...

Shifts in U.S. federal science funding—driven by the newly established Department of Government Efficiency (DOGE)—are causing delays, uncertainty, and program changes across academic and regulatory ...

I joined other leaders from academic medical centers and research institutions in Washington, D.C., to talk with policymakers about the urgent need for continued federal investments in health care and ...

Guidance from the Office of the General Counsel at the Department of Health and Human Services, obtained by STAT, outlines a ...

While the year started out as cautiously optimistic, stemming from the peak of biotech initial public offering (IPO) activity ...

Participants used a variety of strategies to quit, including abrupt cessation (“cold turkey”), switching to other forms of reduced-harm nicotine (such as nicotine patches, gums, lozenges, mouth sprays ...

The global Custom Antibody Market is valued at USD 553.05 Million in 2024 and is projected to reach a value of USD 1237.1 ...

Thermo Fisher's core pharma, biotech, and bioproduction businesses are driving growth. Click here to read why TMO stock is a ...

Trump administration funding cuts and dismantling of USAID force the focus to shift from elimination back to treatment.

Rep. Bonnie Watson Coleman has reintroduced the “Pursuing Equity in Mental Health Act,” a bill designed to address the mental health crisis affecting youth, particularly Black youth, by increasing ...